Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
UBS
Argus Health
Citi
Medtronic
Cerilliant
McKinsey
Moodys
Teva

Generated: June 24, 2018

DrugPatentWatch Database Preview

PYRIDOSTIGMINE BROMIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Pyridostigmine Bromide patents expire, and what generic alternatives are available?

Pyridostigmine Bromide is a drug marketed by Alvogen Malta, Impax Labs Inc, Kinedexe Uk, Ani Pharms Inc, Impax Labs, Solvay, Us Army, and Zydus Pharms Usa Inc. and is included in nine NDAs.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Drug patent expirations by year for PYRIDOSTIGMINE BROMIDE
Pharmacology for PYRIDOSTIGMINE BROMIDE
Medical Subject Heading (MeSH) Categories for PYRIDOSTIGMINE BROMIDE

US Patents and Regulatory Information for PYRIDOSTIGMINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 204737-001 Jun 26, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs Inc PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040457-001 Dec 26, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040512-002 Jul 20, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Solvay PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 089572-001 Nov 27, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Cipla
Chubb
Covington
UBS
Argus Health
Healthtrust
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.